Literature DB >> 8358166

Origin and differentiation of gut endocrine cells.

B B Rawdon1, A Andrew.   

Abstract

The epithelium of the digestive tract contains endocrine cells which produce serotonin and an array of regulatory peptides. It is now irrefutably established that gut endocrine cells are not of neural crest nor even of neurectodermal origin. Furthermore, the proposal that they might originate from neuroendocrine-programmed epiblast has been retused by recent evidence that they share the endodermal stem cell pool with the other epithelial cells of the gut. Based on the available evidence, a working hypothesis for the differentiation of gut endocrine cells has been developed. It is proposed that initially the developing gut acquires an underlying tendency to differentiate into intestine: the endoderm has the potential to form a wide range of endocrine cell types. A little later, some influence operative over the length of the presumptive gut imposes a regionally specific pattern on the tract. This process concerns morphogenesis and pre-selection of the range and proportions of the endocrine cell types. Thereafter, the mesenchyme feeds to the endoderm confirmatory signals reinforcing this pre-selected regional pattern of endocrine cells. Once the different endocrine cell types have started to differentiate, their maturation is effected by circulating factors which include glucocorticoid hormone: this process is mediated by the mesenchyme. Other factors concerned at various stages of gut endocrine cell differentiation could be other hormones, growth factors and or components of extracellular matrix: such factors are still untested in this context.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8358166

Source DB:  PubMed          Journal:  Histol Histopathol        ISSN: 0213-3911            Impact factor:   2.303


  13 in total

1.  Early precursor of mixed endocrine-exocrine tumors of the gastrointestinal tract: histologic and molecular correlations.

Authors:  Fateh Bazerbachi; Taher R Kermanshahi; Carmela Monteiro
Journal:  Ochsner J       Date:  2015

2.  Endocrine cells in the ileum of patients with irritable bowel syndrome.

Authors:  Magdy El-Salhy; Odd Helge Gilja; Doris Gundersen; Jan Gunnar Hatlebakk; Trygve Hausken
Journal:  World J Gastroenterol       Date:  2014-03-07       Impact factor: 5.742

Review 3.  Gut endocrine cell development.

Authors:  Catherine Lee May; Klaus H Kaestner
Journal:  Mol Cell Endocrinol       Date:  2009-12-16       Impact factor: 4.102

Review 4.  Recent developments in the pathophysiology of irritable bowel syndrome.

Authors:  Magdy El-Salhy
Journal:  World J Gastroenterol       Date:  2015-07-07       Impact factor: 5.742

Review 5.  Is irritable bowel syndrome an organic disorder?

Authors:  Magdy El-Salhy; Doris Gundersen; Odd Helge Gilja; Jan Gunnar Hatlebakk; Trygve Hausken
Journal:  World J Gastroenterol       Date:  2014-01-14       Impact factor: 5.742

6.  Enteroendocrine cells, stem cells and differentiation progenitors in rats with TNBS-induced colitis.

Authors:  Magdy El-Salhy; Tarek Mazzawi; Kazuo Umezawa; Odd Helge Gilja
Journal:  Int J Mol Med       Date:  2016-10-24       Impact factor: 4.101

Review 7.  Effect of diet and individual dietary guidance on gastrointestinal endocrine cells in patients with irritable bowel syndrome (Review).

Authors:  Tarek Mazzawi; Magdy El-Salhy
Journal:  Int J Mol Med       Date:  2017-08-11       Impact factor: 4.101

Review 8.  Gastrinoma and neurofibromatosis type 2: the first case report and review of the literature.

Authors:  Sara Massironi; Alessandra Zilli; Roberta Elisa Rossi; Federica Cavalcoli; Dario Conte; Maddalena Peracchi
Journal:  BMC Gastroenterol       Date:  2014-06-24       Impact factor: 3.067

9.  Increased gastric chromogranin A cell density following changes to diets of patients with irritable bowel syndrome.

Authors:  Tarek Mazzawi; Doris Gundersen; Trygve Hausken; Magdy El-Salhy
Journal:  Mol Med Rep       Date:  2014-08-18       Impact factor: 2.952

10.  Abnormalities in ileal stem, neurogenin 3, and enteroendocrine cells in patients with irritable bowel syndrome.

Authors:  Magdy El-Salhy; Odd Helge Gilja
Journal:  BMC Gastroenterol       Date:  2017-08-01       Impact factor: 3.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.